Tyratech Inc (TYR)

 
This US company’s shares are traded by us as on the LSE. Income from them will not be treated as eligible for a reduced rate of tax. Learn more

TYR Share PerformanceMore

52 week high3.2730 05/01/18
52 week low0.8201 14/08/17
52 week change 0.9000 (45.00%)
4 week volume4,383,767 21/12/17

Media for (TYR)

Presenter: Bruno Jactel, CEO
04/02/2015

Latest NewsMore

TyraTech raises $8.4m

TyraTech confirmed that it had raised around $8.4m from a tender offer of shares, representing about 55.8% of the compa...

Result of Tender Offer

RNS Number: 8071B TyraTech, Inc. 15 January 2018 For immediate release: 15 th January 2018 The following announcement replaces that which was released on 5 January 2018 at 7:00am RNS number 0361B. The previous announcement included the Company's 1,084,413 Common Shares which are held in Treasury when calculating the denominator to be used by Shar...

TR-1

RNS Number: 6424B TyraTech, Inc. 11 January 2018 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Tyratech, Inc. 213800YO...

TR-1

RNS Number: 4101B TyraTech, Inc. 09 January 2018 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Tyratech Inc 1b. Please ...

TyraTech completes tender offer

TyraTech said it had completed a tender offer to raise around $8.4m. New shares were issued at 3p each and represented ab...

Result of Tender Offer

RNS Number: 0361B TyraTech, Inc. 05 January 2018 For immediate release: 5 th January 2018 TYRATECH, INC. ("TyraTech" or the "Company") Result of Tender Offer TyraTech Inc. (AIM: TYR, and TYRU), the life sciences company focused on nature-derived insect and parasite control products, is pleased to announce the results of the Tender Offer, details of whi...

Green light for TyraTech to sell Vamousse brand to Alliance Pharma

Life sciences company TyraTech has been given permission by its shareholders to sell its human lice products brand Vam...

Result of Special Meeting

RNS Number: 3980A TyraTech, Inc. 28 December 2017 For immediate release: 28 December 2017 TYRATECH, INC. ("TyraTech" or the "Company") Result of Special Meeting Sale of Vamousse TyraTech Inc. (AIM: TYR, and TYRU), the life sciences company focused on nature-derived insect and parasite control products, announces that at the Special Meeting which ...

Fundamental DataMore

EPS-1
Dividend yield0 %

Latest discussion posts More

Users' HoldingsMore

Users who hold Tyratech Inc also hold..

Codes & Symbols

ISINUSU890581080
SymbolsTYR, LSE:TYR, TYR.L, TYR:LN, LON:TYR, XLON:TYR

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account